TELFAST TABLET 180 MG [SIN11699P]
Active ingredients: TELFAST TABLET 180 MG
Product Info
TELFAST TABLET 180 MG
[SIN11699P]
Product information
Active Ingredient and Strength | FEXOFENADINE HCL - 180 MG |
Dosage Form | TABLET, FILM COATED |
Manufacturer and Country | SANOFI VIETNAM SHAREHOLDING COMPANY - VIETNAM SOC REP OF |
Registration Number | SIN11699P |
Licence Holder | OPELLA HEALTHCARE SINGAPORE PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | R06AX26 |
Prescription-only Medicines with Exemptions for Supply without Prescription | As an oral solid preparation containing not more than 180mg
|
Indication
Indications
Telfast 180mg is indicated for the relief of symptoms associated with Seasonal Allergic Rhinitis (SAR) and Chronic Idiopathic Urticaria (CIU) in adults and children 12 years of age and older.
Dosing
Dosage and method of administration
Adults and children aged 12 years and older
The recommended dose is one tablet once daily.
Special risk groups
Studies in special risk groups (elderly, renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in these patients.
Contraindications
Contraindications
Fexofenadine is contraindicated in patients with known hypersensitivity to any of its ingredients.
